DMXE stands for Deoxymethoxetamine, a dissociative substance belonging to the arylcyclohexylamine class. It is structurally related to compounds like methoxetamine (MXE), ketamine, PCE, and 3-MeO-PCP. DMXE is known for producing ketamine-like dissociative effects, such as euphoria, dissociation, and sensory disconnection, often with a clear-headed and stimulating quality compared to other dissociatives like DXM or ketamine. It emerged around October 2020 as a research chemical, marketed online as a legal alternative to MXE after MXE was banned globally. Chemically, DMXE differs from MXE by replacing the 3-methoxy group with a methyl group, which subtly alters its properties. It acts primarily as an NMDA receptor antagonist, disrupting normal neural signaling, which is responsible for its dissociative effects. Due to its recent emergence, limited data exists on its long-term effects, metabolism, or toxicity, and it is primarily used in research contexts rather than recreationally on a wide scale.